About Enzyme
Enzyme is a company based in San Francisco (United States) founded in 2016 by Jared Seehafer and Jacob Graham was acquired by Greenlight Guru in July 2025. Enzyme has raised $1.97 million across 2 funding rounds from investors including Greenlight Guru, Refactor Capital and DCVC. The company has 19 employees as of December 31, 2022. Enzyme offers products and services including Enzyme QMS, Document Control, Change Control, and Risk Management. Enzyme operates in a competitive market with competitors including Qualio, MasterControl, Legit, Dot Compliance and Greenlight Guru, among others.
- Headquarter San Francisco, United States
- Employees 19 as on 31 Dec, 2022
- Founders Jared Seehafer, Jacob Graham
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Enzyme Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.97 M (USD)
in 2 rounds
-
Latest Funding Round
$1.85 M (USD), Seed
Jan 18, 2018
-
Investors
Greenlight Guru
& 6 more
-
Employee Count
19
as on Dec 31, 2022
-
Acquired by
Greenlight Guru
(Jul 24, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enzyme
Enzyme offers a comprehensive portfolio of products and services, including Enzyme QMS, Document Control, Change Control, and Risk Management.
Platform for document control and compliance in life sciences.
Tool for managing and tracking regulatory documents.
System for overseeing changes in quality processes.
Software for identifying and mitigating risks in products.
People of Enzyme
Unlock access to complete
Unlock access to complete
Funding Insights of Enzyme
Enzyme has successfully raised a total of $1.97M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.85 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Enzyme
Enzyme has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include Greenlight Guru, Refactor Capital and DCVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage investments are made across US and India.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Digital Health focused VC & Accelerator firm investing in the US
|
Locked | Locked | Locked |
Investor details for Enzyme
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enzyme
Investment portfolio details for Enzyme
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Enzyme
Detailed financials for Enzyme
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enzyme Comparisons
Peer comparison for Enzyme
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enzyme
Enzyme operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qualio, MasterControl, Legit, Dot Compliance and Greenlight Guru, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Web-based quality management software is delivered for life sciences firms.
|
|
| Locked | Locked | Locked |
Provider of governance, risk and compliance solutions for life sciences industries
|
|
| Locked | Locked | Locked |
Legit is recognized as a pioneer in privacy and data protection, offering innovative RegTech solutions.
|
|
| Locked | Locked | Locked |
Cloud based quality management software
|
|
| Locked | Locked | Locked |
Cloud-based quality management software is offered for medical device manufacturers.
|
|
| Locked | Locked | Locked |
Cloud-based quality management software is offered for organizational processes.
|
Detailed competitors of Enzyme
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enzyme
Complete news archive for Enzyme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enzyme
Enzyme was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Enzyme is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Jared Seehafer is the current CEO of Enzyme. They have also founded this company.
Enzyme is a funded company, having raised a total of $1.97M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Enzyme is 19.
Enzyme was founded in 2016 in San Francisco, United States, and operates in the healthcare technology sector. A cloud-based quality management system is offered to medical device and diagnostic companies for managing FDA compliance workflows. Compliance and quality systems are delivered as a service through a web application, supporting operations in gaining and maintaining regulatory adherence.
Enzyme's top competitors include Qualio, MasterControl and Greenlight Guru.
Enzyme offers Enzyme QMS, Document Control, Change Control, and Risk Management.
Enzyme has 7 investors. Key investors include Greenlight Guru, Refactor Capital, DCVC, Rock Health, and Elizabeth Iorns.